Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH
Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.
Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.
Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.
Varicose veins significantly increased the risk for deep vein thrombosis and may also increase the risk for pulmonary embolism and peripheral artery disease.
A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.
Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.
Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.
Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.
The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.
Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.
To minimize the “learning effect” and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.